Riding a motorcycle is associated with a high risk of fatal crashes, both in Australia and in many other parts of the world. Accounting for only 4.5 percent of Australian vehicle registrations, motorcycle riders account for an alarming 15 percent of road deaths.
Intravenous drips first came into prominence during World War One and the method of injecting a simple hydrating solution into the vein is still used to maintain body fluid, aid the output of the heart, and stabilise and maintain blood pressure.
The George Institute for Global Health and the University of Sydney’s Discipline of Paediatrics and Child Health, have been recognised and highly praised by Mick Gooda, Australia’s Aboriginal and Torres Strait Islander Social Justice Commissioner for addressing Fetal Alcohol Spectrum Disorders (FASD) in partnership with Aboriginal communities in the Fitzroy Valley.
Traffic Light Labelling to help consumers identify healthier food products was one of the key recommendations of the Blewett committee report published last week1. Many public health groups welcome this recommendation. However, in a direct attempt to subvert the process, the Australian Food and Grocery Council (AFGC) yesterday launched a new campaign2 promoting its controversial Daily Intake Guide labelling scheme - widely criticized by public interest groups as not adequately protecting consumers health.
The George Institute for Global Health has announced that Susan Murray, outgoing General Manager and Chief Executive Officer of the Australian National Breast Cancer Foundation is to join The George Institute as Executive Director of The George Foundation in February 2011.
A review by experts from Sydney-based The George Institute for Global Health has revealed a startling lack of evidence of whether pre and post licence training is effective in reducing death and serious injury for motorcycle riders.
The world’s largest kidney disease trial of over 9,400 volunteers aged 40 or over with chronic kidney disease, 2,281 of whom were recruited from 64 sites in Australia, New Zealand, Malaysia and Thailand, has shown that the combination of the cholesterol-lowering drugs ezetimibe and simvastatin could reduce by a quarter all heart attacks, strokes and operations to open blocked arteries in people with chronic kidney disease.